Phase I Study of Pharmacokinetics and Safety of Ravidasvir in Combination With Ritonavir-boosted Danoprevir in Single and Multiple Doses in Healthy Participants

Trial Profile

Phase I Study of Pharmacokinetics and Safety of Ravidasvir in Combination With Ritonavir-boosted Danoprevir in Single and Multiple Doses in Healthy Participants

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 22 Nov 2017

At a glance

  • Drugs Danoprevir/ritonavir (Primary) ; Ravidasvir (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions
  • Sponsors Ascletis
  • Most Recent Events

    • 15 Nov 2017 Planned End Date changed from 1 Oct 2017 to 1 Feb 2018.
    • 15 Nov 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Dec 2017.
    • 20 Sep 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Oct 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top